unknown
Stage
About
Delve Bio develops a metagenomic next-generation sequencing (mNGS) diagnostic test called Delve Detect that rapidly identifies bacteria, viruses, fungi, and parasites in cerebrospinal fluid to diagnose central nervous system infections such as meningitis and encephalitis.
Explore Delve Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.